MEDOCHEMIE LTD

Medochemie is a global pharmaceutical company that develops, manufactures and commercializes Generics, with its Headquarters in Cyprus and a network of 21 subsidiaries in Europe and overseas.

Employs 1,880 highly skilled professionals, holds 4,355 marketing authorizations and owns 13 manufacturing sites in Cyprus, The Netherlands and Vietnam, designed to fully comply with European and WHO current Good Manufacturing Practices (cGMPs).

The company operates for over 40 years bringing its therapies to patients in 107 countries around the globe with products that range between 10 therapeutic categories in oral, parenteral and topical presentations, including penicillins, cephalosporins and dry powder inhalers.

We offer unique commercial expertise based on a global footprint by having established operations and long-term trusted partnerships in over 107 markets around the world. 

With our sustained investment in growing our pharmaceutical operations, we keep expanding our business network always with commitment and dedication to quality and safety.

For more information, visit our website: www.medochemie.com